Yun Jee Kang

697 total citations
10 papers, 93 citations indexed

About

Yun Jee Kang is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yun Jee Kang has authored 10 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Yun Jee Kang's work include CAR-T cell therapy research (4 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (2 papers). Yun Jee Kang is often cited by papers focused on CAR-T cell therapy research (4 papers), Glioma Diagnosis and Treatment (4 papers) and Brain Metastases and Treatment (2 papers). Yun Jee Kang collaborates with scholars based in United States, China and Saudi Arabia. Yun Jee Kang's co-authors include Wenya Linda Bi, Shakti Ramkissoon, Ian F. Dunn, Keith L. Ligon, David A. Reardon, Malak Abedalthagafi, Sashank Prasad, Ian F. Dunn, Helen A. Shih and Winona Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncotarget.

In The Last Decade

Yun Jee Kang

8 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yun Jee Kang United States	6	41	37	26	24	22	10	93
Carlo Sagramoso Italy	7	29 0.7×	10 0.3×	57 2.2×	15 0.6×	37 1.7×	11	86
Naomi Fujimoto Japan	5	40 1.0×	28 0.8×	13 0.5×	34 1.4×	3 0.1×	9	80
Alvaro G. Menendez United States	5	14 0.3×	17 0.5×	10 0.4×	14 0.6×	33 1.5×	15	85
Anne Lazareth France	7	28 0.7×	14 0.4×	28 1.1×	15 0.6×	17 0.8×	13	88
Guido Ghilardi United States	6	27 0.7×	47 1.3×	16 0.6×	7 0.3×	36 1.6×	19	95
Illja J. Diets Netherlands	7	13 0.3×	36 1.0×	44 1.7×	36 1.5×	31 1.4×	8	113
Zsolt Nagy Hungary	5	13 0.3×	32 0.9×	31 1.2×	14 0.6×	18 0.8×	15	85
Verena Dreschmann Germany	5	82 2.0×	24 0.6×	5 0.2×	40 1.7×	5 0.2×	5	119
Ares Solanes Spain	6	5 0.1×	34 0.9×	28 1.1×	23 1.0×	16 0.7×	9	97
Adolfo de la Fuente Spain	6	31 0.8×	11 0.3×	44 1.7×	37 1.5×	19 0.9×	20	102

Countries citing papers authored by Yun Jee Kang

Since Specialization

Citations

This map shows the geographic impact of Yun Jee Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Jee Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Jee Kang more than expected).

Fields of papers citing papers by Yun Jee Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Jee Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Jee Kang. The network helps show where Yun Jee Kang may publish in the future.

Co-authorship network of co-authors of Yun Jee Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Jee Kang. A scholar is included among the top collaborators of Yun Jee Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Jee Kang. Yun Jee Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Luo, Wenjing, Yinqiang Zhang, Chenggong Li, et al.. (2025). BTK Inhibitor Synergizes With CD19 ‐Targeted Chimeric Antigen Receptor‐T Cells in Patients With Relapsed or Refractory B‐Cell Lymphoma: An Open‐Label Pragmatic Clinical Trial. Cancer Medicine. 14(20). e71321–e71321.

Wang, Xindi, Wenjing Luo, Zhaozhao Chen, et al.. (2025). Co-expression of IL-15 and CCL21 strengthens CAR-NK cells to eliminate tumors in concert with T cells and equips them with PI3K/AKT/mTOR signal signature. Journal for ImmunoTherapy of Cancer. 13(6). e010822–e010822. 2 indexed citations

Luo, Wenjing, Yinqiang Zhang, Chenggong Li, et al.. (2024). BTK Inhibitor Synergizes with CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients with Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial. Blood. 144(Supplement 1). 6546–6546. 1 indexed citations

Luo, Wenjing, Chenggong Li, Jianghua Wu, et al.. (2023). Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma. Cytotherapy. 25(7). 739–749. 14 indexed citations

Kang, Yun Jee, Jeffrey M. Farma, & Chandrajit P. Raut. (2022). Special clinical scenarios in RPS: Involvement of great vessels and pancreas and penetration across natural foramina. European Journal of Surgical Oncology. 49(6). 1091–1101.

Bernstock, Joshua D., Brandon M. Fox, Houman Sotoudeh, et al.. (2019). Cauda equina syndrome in an ovarian malignant‐mixed müllerian tumor with leptomeningeal spread. SHILAP Revista de lepidopterología. 7(12). 2341–2345. 7 indexed citations

Abedalthagafi, Malak, Wenya Linda Bi, Yun Jee Kang, et al.. (2016). Genomic characterization of recurrent high-grade astroblastoma. Cancer Genetics. 209(7-8). 321–330. 12 indexed citations

Miller, Michael B., Wenya Linda Bi, Lori Ramkissoon, et al.. (2016). MAPK activation andHRASmutation identified in pituitary spindle cell oncocytoma. Oncotarget. 7(24). 37054–37063. 25 indexed citations

Kang, Yun Jee, Wenya Linda Bi, Adrian M. Dubuc, et al.. (2015). Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation. World Neurosurgery. 85. 96–105. 10 indexed citations

10.

Wu, Winona, Wenya Linda Bi, Yun Jee Kang, et al.. (2015). Adult Atypical Teratoid/Rhabdoid Tumors. World Neurosurgery. 85. 197–204. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact